Yale: Experimental Drug Reverses Synaptic Loss in Mouse Models of Alzheimer's
June 01, 2022
June 01, 2022
NEW HAVEN, Connecticut, June 1 (TNSjou) -- Yale University issued the following news:
An experimental drug restored brain synapses in two mouse models of Alzheimer's disease, raising hopes that it could help revive cognitive function in human dementia patients, Yale University researchers report June 1 in the journal Science Translational Medicine.
While much research in Alzheimer's has centered on reducing levels of beta-amyloid plaque in the brain that is a . . .
An experimental drug restored brain synapses in two mouse models of Alzheimer's disease, raising hopes that it could help revive cognitive function in human dementia patients, Yale University researchers report June 1 in the journal Science Translational Medicine.
While much research in Alzheimer's has centered on reducing levels of beta-amyloid plaque in the brain that is a . . .